Anbio Biotechnology (NASDAQ:NNNN) Short Interest Up 122.9% in August

Anbio Biotechnology (NASDAQ:NNNN) was the target of a significant growth in short interest during the month of August. As of August 31st, there was short interest totaling 58,423 shares, a growth of 122.9% from the August 15th total of 26,210 shares. Based on an average daily trading volume, of 286,803 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.0% of the company’s stock are short sold.

Anbio Biotechnology Trading Down 9.8%

Shares of NASDAQ NNNN opened at $5.51 on Wednesday. The firm’s 50 day moving average price is $8.74 and its 200-day moving average price is $18.45. Anbio Biotechnology has a 52-week low of $5.25 and a 52-week high of $51.33.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings cut Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, July 29th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.